Beyond the Digestive System: Understanding Gut-Brain-Microbiome Axis in Irritable Bowel Syndrome
DOI:
https://doi.org/10.51985/JBUMDC2023186Keywords:
Functional Disorders, Gut-Brain-Axis, Irritable Bowel Syndrome, MicrobiotaAbstract
IBS affects a significant number of people worldwide, particularly those under the age of 50, with women being twice as
likely to be affected than men. Although the underlying pathophysiology of IBS is not yet fully comprehended, current
research indicates that it could be related to the Gut-Brain Axis (GBA). This communication is vital to the intricate balance
of the gastrointestinal system. Through this axis intestinal motility, secretion, and sensation are harmoniously regulated,
resulting in efficient digestion and optimal nutrient absorption. Disturbance in the Gut-Brain Axis is linked to a broad
spectrum of psychiatric and gastrointestinal disorders, including IBS. Managing IBS effectively requires a multidisciplinary
approach, including dietary modifications, stress management techniques, medications, and psychological therapies. Proper
management of IBS can lead to a healthy and fulfilling life for individuals affected by the disorder. Further studies are
required to clarify the causes and development of most effective treatments for IBS
References
Oka P, Parr H, Barberio B, Black CJ, Savarino E V., Ford
AC. Global prevalence of irritable bowel syndrome according
to Rome III or IV criteria: a systematic review and metaanalysis. Lancet Gastroenterol Hepatol. 2020;5(10):908–17
DOI: https://doi.org/10.1016/S2468-1253(20)30217-X
Camilleri M. Diagnosis and Treatment of Irritable Bowel
Syndrome: A Review. JAMA. 2021;325(9):865–77 DOI:
1001/jama.2020.22532
Black CJ, Ford AC. Global burden of irritable bowel syndrome:
trends, predictions and risk factors. Nat Rev Gastroenterol
Hepatol. 2020;17(8):473–86 DOI: https://doi.org/10.1038
/s41575-020-0286-8
Margolis KG, Cryan JF, Mayer EA. The Microbiota-GutBrain Axis: From Motility to Mood. Gastroenterology.
;160(5):1486–501
Ancona A, Petito C, Iavarone I, Petito V, Galasso L, Leonetti
A, et al. The gut–brain axis in irritable bowel syndrome and
inflammatory bowel disease. Digestive and Liver Disease.
;53(3):298–305 DOI: https://doi.org/10.1016
/j.dld.2020.11.026
Altomare A, Di Rosa C, Imperia E, Emerenziani S, Cicala
M, Guarino MPL. Diarrhea Predominant-Irritable Bowel
Syndrome (IBS-D): Effects of Different Nutritional Patterns
on Intestinal Dysbiosis and Symptoms. Nutrients
;13(5):1506 DOI: https://doi.org/10.3390/nu13051506
Niesler B, Kuerten S, Demir IE, Schäfer KH. Disorders of
the enteric nervous system - a holistic view. Nat Rev
Gastroenterol Hepatol. 2021;18(6):393-410 DOI: 10.1038
/s41575-020-00385-2
Herndon CC, Wang YP, Lu CL. Targeting the gut microbiota
for the treatment of irritable bowel syndrome. Kaohsiung
Journal of Medical Sciences. 2020;36(3):160–70 DOI:
https://doi.org/10.1002/kjm2.12154
Quddus MA, Shahzad A, Munawar R, Maqbool KT, Mansoor
A. Rifaximin : An Option for the Treatment of Irritable Bowel
Syndrome. 2021;16(4):215–8.
Ancona A, Petito C, Iavarone I, Petito V, Galasso L, Leonetti
A, et al. The gut–brain axis in irritable bowel syndrome and
inflammatory bowel disease. Digestive and Liver Disease.
;53(3):298–305.
Binienda A, Salaga M. Genetic aspect (with SNPs) of irritable
bowel syndrome. A Comprehensive Overview of Irritable
Bowel Syndrome. 2020;85–97.
Hu M, Zhang X, Li J, Chen L, He X, Sui T. Fucosyltransferase
: A Genetic Risk Factor for Intestinal Diseases. Front
Microbiol. 2022;13.
Camilleri M, Zhernakova A, Bozzarelli I, D’Amato M.
Genetics of irritable bowel syndrome: shifting gear via biobankscale studies. Nature Reviews Gastroenterology & Hepatology
19:11. 2022;19(11):689–702 DOI: https://doi.org/10.1038
/s41575-022-00662-2
LUTA G, LEFTER R, CIOBICA A, BALMUS IM,
MAVROUDIS I, CIMPEANU SC, et al. A Preliminary view
on some Genetic Aspects of Irritable Bowel Syndrome with
regards to Neuropsychiatric Manifestations –. Annals of the
Academy of Romanian Scientists Series on Biological
Sciences. 2022;11(1):104–8.
Xiao QY, Fang XC, Li XQ, Fei GJ. Ethnic differences in
genetic polymorphism associated with irritable bowel
syndrome. World J Gastroenterol. 2020;26(17):2049–63.
Savarino E, Zingone F, Barberio B, Marasco G, Akyuz F,
Akpinar H, et al. Functional bowel disorders with diarrhoea:
Clinical guidelines of the United European Gastroenterology
and European Society for Neurogastroenterology and Motility.
United European Gastroenterol J. 2022;10(6):556–84.
Törnblom H, Drossman DA. Psychopharmacologic Therapies
for Irritable Bowel Syndrome. Gastroenterol Clin North Am.
;50(3):655–69 DOI: https://doi.org/10.1016 /j.gtc.
04.005
Horn A, Stangl S, Parisi S, Bauer N, Roll J, Löffler C, et al.
Systematic review with meta-analysis: Stress-management
interventions for patients with irritable bowel syndrome. Stress
and Health. 2023.
Kim, J., Cho, K., Kim, J.S. et al. Probiotic treatment induced
change of inflammation related metabolites in IBS-D
patients/double-blind, randomized, placebo-controlled trial.
Food Sci Biotechnol 29, 837–844 (2020) DOI: https://
doi.org/10.1007/s10068-019-00717-2
Ghoshal UC, Nehra A, Mathur A, Rai S. A meta-analysis on
small intestinal bacterial overgrowth in patients with different
subtypes of irritable bowel syndrome. J Gastroenterol Hepatol.
;35(6):922–31 DOI: https://doi.org/10.1111/jgh.14938
Mukhtar K, Nawaz H, Abid S. Functional gastrointestinal
disorders and gut-brain axis: What does the future hold?
World J Gastroenterol. 2019;25(5):552–66.
Quigley EMM. The gut-brain axis and the microbiome: Clues
to pathophysiology and opportunities for novel management
strategies in irritable bowel syndrome (IBS). Vol. 7, Journal
of Clinical Medicine. MDPI; 2018.
Takakura W, Pimentel M. Small Intestinal Bacterial
Overgrowth and Irritable Bowel Syndrome – An Update.
Front Psychiatry. 2020; 11:664.
Mishima Y, Ishihara S. Enteric microbiota-mediated
serotonergic signaling in pathogenesis of irritable bowel
syndrome. Int J Mol Sci. 2021;22(19).
Banfi D, Moro E, Bosi A, Bistoletti M, Cerantola S, Crema
F, et al. Impact of Microbial Metabolites on Microbiota –
Gut–Brain Axis in Inflammatory Bowel Disease. Int J Mol
Sci. 2021;22(4):1623 DOI: https://doi.org/10.3390/
ijms22041623
Mogilevski T, Burgell R, Aziz Q, Gibson PR. Review article:
the role of the autonomic nervous system in the pathogenesis
and therapy of IBD. Aliment Pharmacol Ther. 2019;50(7)
:720–37.
Wang L, Alammar N, Singh R, Nanavati J, Song Y, Chaudhary
R, et al. Gut Microbial Dysbiosis in the irritable bowel
syndrome: A Systematic Review and Meta-Analysis of CaseControl Studies. J Acad Nutr Diet. 2020;120(4):565–86.
Barandouzi ZA, Lee J, Maas K, Starkweather AR, Cong XS.
Altered gut microbiota in irritable bowel syndrome and its
association with food components. J Pers Med.
;11(1):1–19.
El-Salhy M. Possible role of intestinal stem cells in the
pathophysiology of irritable bowel syndrome. World J
Gastroenterol. 2020;26(13):1427–38.
Black CJ, Yiannakou Y, Guthrie EA, West R, Houghton LA,
Ford AC. A Novel Method to Classify and Subgroup Patients
With IBS Based on Gastrointestinal Symptoms and
Psychological Profiles. Am J Gastroenterol. 2021;116(2):
–81 DOI: 10.14309/ajg.0000000000000975
Shrestha B, Patel D, Shah H, Hanna KS, Kaur H, Alazzeh
MS, et al. The Role of Gut-Microbiota in the Pathophysiology
and Therapy of Irritable Bowel Syndrome: A Systematic
Review. Cureus. 2022;14(8).
Black CJ, Yiannakou Y, Houghton LA, Shuweihdi F, West
R, Guthrie E, et al. Anxiety-related factors associated with
symptom severity in irritable bowel syndrome.
Neurogastroenterology and Motility. 2020;32(8) DOI: https://
doi. org/10.1111/nmo.13872
Midenfjord I, Borg A, Törnblom H, Simrén M. Cumulative
Effect of Psychological Alterations on Gastrointestinal
Symptom Severity in Irritable Bowel Syndrome. Am J
Gastroenterol. 2021;116(4):769–79 DOI: 10.14309/ajg.
Goodoory VC, Mikocka-Walus A, Yiannakou Y, Houghton
LA, Black CJ, Ford AC. Impact of Psychological Comorbidity
on the Prognosis of Irritable Bowel Syndrome. Am J
Gastroenterol. 2021;116(7):1485–94 DOI: 10.14309/ajg.
Fairbrass KM, Gracie DJ, Ford AC. Longitudinal follow-up
study: effect of psychological co-morbidity on the prognosis
of inflammatory bowel disease. Aliment Pharmacol Ther.
;54(4):441–50 DOI: https://doi.org/10.1111/apt.16454
Rengarajan S, Knoop KA, Rengarajan A, Chai JN, GrajalesReyes JG, Samineni VK, et al. A Potential Role for StressInduced Microbial Alterations in IgA-Associated Irritable
Bowel Syndrome with Diarrhea. Cell Rep Med.
;1(7):100124 DOI: https://doi.org/10.1016 /j.xcrm
.2020.100124
Principi N, Cozzali R, Farinelli E, Brusaferro A, Esposito S.
Gut dysbiosis and irritable bowel syndrome: The potential
role of probiotics. Journal of Infection. 2018;76(2):111–20.
Wang Z, Xu CM, Liu YX, Wang XQ, Zhang L, Li M, et al.
Characteristic dysbiosis of gut microbiota of Chinese patients
with diarrhea-predominant irritable bowel syndrome by an
insight into the pan-microbiome. Chin Med J (Engl).
;132(8):889–904.
Vahora IS, Tsouklidis N, Kumar R, Soni R, Khan S. How
Serotonin Level Fluctuation Affects the Effectiveness of
Treatment in Irritable Bowel Syndrome. Cureus. 2020.
Kader A, Nasirullah M, Mohiuddin AK. Conventional and
Alternative Measures for IBS Management. Open Journal of
Gastroenterology and Hepatology. 2019;2(1):11–5.
Camilleri M. Current and future pharmacological treatments
for diarrhea-predominant irritable bowel syndrome. Expert
Opin Pharmacother. 2013;14(9):1151–60
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Rashid Ali Khosa, Syed Ijaz Hussain Zaidi, Muhammad Sajid Abbas Jaffri, Shahid Mehmood, Allah Bakhsh
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Journal of Bahria University Medical & Dental College is an open access journal and is licensed under CC BY-NC 4.0. which permits unrestricted non commercial use, distribution and reproduction in any medium, provided the original work is properly cited. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc/4.0 
